Literature DB >> 1545069

Effect of acetylcholine on the highly stenotic coronary artery: difference between the constrictor response of the infarct-related coronary artery and that of the noninfarct-related artery.

K Okumura1, H Yasue, K Matsuyama, H Ogawa, Y Morikami, K Obata, N Sakaino.   

Abstract

To examine the constrictor response of the infarct-related stenotic coronary artery in comparison with that of noninfarct-related stenotic arteries, acetylcholine in maximal doses of 100 micrograms for the left and 50 micrograms for the right coronary artery was injected into the 16 infarct-related coronary arteries of 16 patients with previous myocardial infarction (group 1) and into 19 stenotic coronary arteries of 16 patients with stable angina without myocardial infarction (group 2). Acetylcholine's effects on lumen diameter and area were quantitatively analyzed at the stenotic segment and its proximal segment without significant stenosis. Acetylcholine decreased lumen diameter and area at the stenotic segments from 0.72 +/- 0.18 to 0.18 +/- 0.33 mm and from 0.45 +/- 0.22 to 0.10 +/- 0.22 mm2, respectively, in group 1 (both p less than 0.01) and from 0.75 +/- 0.22 to 0.49 +/- 0.30 mm and 0.48 +/- 0.29 to 0.26 +/- 0.23 mm2, respectively, in group 2 (both p less than 0.01). Acetylcholine decreased the diameter and area at the proximal segment from 2.71 +/- 0.75 to 2.38 +/- 0.6 mm and from 6.18 +/- 3.4 to 4.71 +/- 2.23 mm2, respectively, in group 1 (both p less than 0.01) and from 2.31 +/- 0.67 to 1.95 +/- 0.59 mm and from 4.5 +/- 2.97 to 3.22 +/- 1.96 mm2, respectively, in group 2 (both p less than 0.01). The changes in diameter and area at the stenotic segment in group 1 were significantly greater than those in group 2 (both p less than 0.01); there were no significant differences between groups in the changes at the proximal segment.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1545069     DOI: 10.1016/0735-1097(92)90513-m

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  8 in total

Review 1.  Exercise and the nitric oxide vasodilator system.

Authors:  Andrew Maiorana; Gerard O'Driscoll; Roger Taylor; Daniel Green
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 2.  Is reversal of endothelial dysfunction still an attractive target in modern cardiology?

Authors:  Ify Mordi; Nikolaos Tzemos
Journal:  World J Cardiol       Date:  2014-08-26

Review 3.  Arterial stiffness as a risk factor for coronary atherosclerosis.

Authors:  Daniel A Duprez; Jay N Cohn
Journal:  Curr Atheroscler Rep       Date:  2007-08       Impact factor: 5.113

4.  Preserved coronary endothelial function by inhibition of delta protein kinase C in a porcine acute myocardial infarction model.

Authors:  Hideaki Kaneda; Fumiaki Ikeno; Koichi Inagaki; Daria Mochly-Rosen
Journal:  Int J Cardiol       Date:  2008-02-01       Impact factor: 4.164

Review 5.  [Endothelial dysfunction in patients with acute coronary syndrome].

Authors:  S Fichtlscherer; A M Zeiher
Journal:  Herz       Date:  1999-11       Impact factor: 1.740

Review 6.  Flavonoids: antioxidants against atherosclerosis.

Authors:  Davide Grassi; Giovambattista Desideri; Claudio Ferri
Journal:  Nutrients       Date:  2010-08-12       Impact factor: 5.717

7.  Persistent Dysfunction of Coronary Endothelial Vasomotor Responses is Related to Atheroma Plaque Progression in the Infarct-Related Coronary Artery of AMI Survivors.

Authors:  Takeo Horikoshi; Jun-Ei Obata; Takamitsu Nakamura; Daisuke Fujioka; Yosuke Watanabe; Kazuto Nakamura; Kazuhiro Watanabe; Yukio Saito; Kiyotaka Kugiyama
Journal:  J Atheroscler Thromb       Date:  2019-04-16       Impact factor: 4.928

8.  Comparison of Endothelial Dysfunction in Coronary Arteries with Bare Metal and 2nd-Generation Drug-Eluting Stents.

Authors:  Yusuke Akiyama; Tetsuya Matoba; Shunsuke Katsuki; Susumu Takase; Soichi Nakashiro; Yasuhiro Nakano; Kensuke Noma; Hiroyuki Tsutsui
Journal:  J Atheroscler Thromb       Date:  2021-02-19       Impact factor: 4.928

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.